Cas:86088-59-7 L-THREONINEBENZYLESTERHEMIOXALATE manufacturer & supplier

Chemical Name:L-THREONINEBENZYLESTERHEMIOXALATE

CAS.NO:86088-59-7

Synonyms:(2S,3R)-Benzyl 2-amino-3-hydroxybutanoate oxalate(2:1);H-THR-OBZL.HEMIOXALATE;H-THR-OBZL HEMIOXALATE;hemioxalate;L-THR-OBZL HEMIOXALATE;H-THR-OBZL 1/2(COOH)2;L-Threonine, phenylmethyl ester, ethanedioate (2:1);H-L-THR-OBZL*0.5OXOH;Benzyl L-threoninate ethanedioate (2:1);THR-OBZL.HEMIOXALATE;benzyl L-threoninate hemioxalate;L-Threonine benzyl ester hemioxalate;L-Thr-O-Bzl;L-THREONINEBENZYLESTERHEMIOXALATE

Molecular Formula:C₂₄H₃₂N₂O₁₀

Molecular Weight:508.518

HS Code:2923900090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:566.3ºC at 760 mmHg

Density:N/A

Index of Refraction:

PSA:147.15000

Exact Mass:508.205688

LogP:0.29380

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (2S,3R)-Benzyl 2-amino-3-hydroxybutanoate oxalate(2:1) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,L-THREONINEBENZYLESTERHEMIOXALATE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzyl L-threoninate ethanedioate (2:1) Use and application,Benzyl L-threoninate ethanedioate (2:1) technical grade,usp/ep/jp grade.

Related News: The third-to-market BTK inhibitor is also looking to report top-line results from a front-line trial later this year. Imbruvica could feel more pressure if that study also turns out successful. L-THREONINEBENZYLESTERHEMIOXALATE manufacturer The third-to-market BTK inhibitor is also looking to report top-line results from a front-line trial later this year. Imbruvica could feel more pressure if that study also turns out successful. L-THREONINEBENZYLESTERHEMIOXALATE supplier In recent years, China’s bulk drug companies have gradually completed the upgrade of the product structure of bulk raw materials to specialty raw materials and intermediates. The industry’s leading companies have further developed the research and development layout of high-barrier generic pharmaceutical raw materials with multiple patents that have not yet expired. L-THREONINEBENZYLESTERHEMIOXALATE vendor The third-to-market BTK inhibitor is also looking to report top-line results from a front-line trial later this year. Imbruvica could feel more pressure if that study also turns out successful. L-THREONINEBENZYLESTERHEMIOXALATE factory API and raw material are often confused due to the similar usage of the two terms.